Figure 5

Cardiomyopathies - The special entity of myocarditis and inflammatory cardiomyopathy

Felicitas Escher*, Uwe Kühl, Dirk Lassner and Heinz-Peter Schultheiss

Published: 01 July, 2019 | Volume 4 - Issue 2 | Pages: 053-070

Mortality rate among patients positive for enterovirus (EV) infection: unadjusted survival according to virus analysis at follow-up. Interferon-β-induced (6 month treatment) enterovirus clearance was associated with a significantly reduced mortality rate in comparison to patients who had enterovirus persistence (p = 0.0005 by the log-rank test). Modified by Kühl, Schultheiss et al. J Am Coll Cardiol. 2012 Oct 2;60(14):1295-6.

" alt="jccm-aid1041-g005"class="img-responsive img-rounded " style="cursor:pointer">

Figure 5:

Mortality rate among patients positive for enterovirus (EV) infection: unadjusted survival according to virus analysis at follow-up. Interferon-β-induced (6 month treatment) enterovirus clearance was associated with a significantly reduced mortality rate in comparison to patients who had enterovirus persistence (p = 0.0005 by the log-rank test). Modified by Kühl, Schultheiss et al. J Am Coll Cardiol. 2012 Oct 2;60(14):1295-6.

Read Full Article HTML DOI: 10.29328/journal.jccm.1001041 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More